ADNP and neoplasm: Consistent with this argument, analyses of clinical data in both the Tothill (Fig. 4b, p = 0.02; HR:1.9) and Yoshihara (Fig. 4c, p = 0.04; HR:1.7) datasets demonstrated that patients whose tumours have high levels of ADNP mRNA expression have a worse prognosis.